NCT00701324 - BI 811283 in Various Solid Tumours | Biotech Hunter

Enrollment

124

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions

Neoplasms

Interventions

DRUG

BI 811283

dose escalation BI 811283, Arm B (3 weeks)

DRUG

BI 811283

dose escalation BI 811283, Arm A (day 1)

DRUG

BI 811283

dose escalation BI 811283, Arm A (day 15)

Trial Locations (2)

1247.1.49002 Boehringer Ingelheim Investigational Site, Essen

1247.1.49001 Boehringer Ingelheim Investigational Site, Freiburg/Breisgau